Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Montelukast in Seasonal Allergic Rhinitis
NCT00960141Phase 3Completed
- Sponsor
- Organon & Co.
- Start
- Aug 2000
- Primary completion
- Oct 2000
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of montelukast in seasonal allergic rhinitis (SAR), sponsored by Organon & Co.. Started Aug 2000; status: completed.
02
Drugs
montelukast
03
Conditions
seasonal allergic rhinitis (SAR)
Beyond the preview
Go deeper on NCT00960141.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00960141.